Anticholinergic drugs compared
Compare all 14 Anticholinergic drugs side by side, used for conditions such as bronchial spasm, bronchitis, pulmonary emphysema. They share one FDA-defined mechanism but differ in approved uses, prescription status, brand-vs-generic options, price, and FDA recall-safety record — which our independent rating scores. The highest-rated is atrovent hfa.
Top-rated anticholinergic: 1. Atrovent Hfa · 2. Spiriva Respimat · 3. Dicyclomine Hydrochloride
| Drug | Generic | Form | Status | Used for | Safety ratingFDA recall-based | Pharmacy pays |
|---|---|---|---|---|---|---|
| Atrovent Hfa | Ipratropium Bromide | Spray/Inhaler | Prescription | Bronchial Spasm, Bronchitis | 72/100 | $1 |
| Spiriva Respimat | Tiotropium Bromide | Spray/Inhaler | Prescription | Pulmonary Emphysema, Bronchitis, Chronic | 72/100 | $354 |
| Dicyclomine Hydrochloride | — | Capsule | Prescription | Irritable Bowel Syndrome | 70/100 | $2 |
| Spiriva | Tiotropium Bromide | Capsule | Prescription | Pulmonary Emphysema, Bronchitis, Chronic | 70/100 | $354 |
| Tudorza Pressair | Aclidinium Bromide | Powder | Prescription | Bronchial Spasm, Pulmonary Disease, Chronic Obstructive | 70/100 | — |
| Atropine Sulfate | — | Injectable | Prescription | Bradycardia, Heart Arrest | Not yet rated | $7 |
| Benztropine Mesylate | — | Injectable | Prescription | Abnormalities, Drug-Induced, Parkinson Disease | Not yet rated | — |
| Cuvposa | Glycopyrrolate | Liquid | Prescription | Hyperhidrosis, Abnormalities, Drug-Induced | Not yet rated | $0 |
| Glycopyrrolate | — | Injectable | Prescription | Hyperhidrosis, Abnormalities, Drug-Induced | Not yet rated | $0 |
| Glyrx-Pf | Glycopyrrolate | Injectable | Prescription | Hyperhidrosis, Abnormalities, Drug-Induced | Not yet rated | $0 |
| Isopto Atropine | Atropine Sulfate | Solution | Prescription | Bradycardia, Heart Arrest | Not yet rated | $7 |
| Robinul | Glycopyrrolate | Tablet | Prescription | Hyperhidrosis, Abnormalities, Drug-Induced | Not yet rated | $0 |
The safety rating column is unique to pharmaranks — an independent 0–100 score from FDA regulatory recall data. Higher is safer. Not medical advice.
Best anticholinergic by condition
Full ranking · 14 drugs
- 172/100
atrovent hfa
Ipratropium Bromide
- 272/100
spiriva respimat
Tiotropium Bromide
- 370/100
dicyclomine hydrochloride
Dicyclomine Hydrochloride
- 470/100
spiriva
Tiotropium Bromide
- 570/100
tudorza pressair
Aclidinium Bromide
- 6New
atropine sulfate
Atropine Sulfate
- 7New
benztropine mesylate
Benztropine Mesylate
- 8New
cuvposa
Glycopyrrolate
- 9New
glycopyrrolate
Glycopyrrolate
- 10New
glyrx-pf
Glycopyrrolate
- 11New
isopto atropine
Atropine Sulfate
- 12New
robinul
Glycopyrrolate
- 13New
robinul forte
Glycopyrrolate
- 14New
transderm scop
Scopolamine
Frequently asked questions
What is the Anticholinergic drug class?
Anticholinergic is an FDA Established Pharmacologic Class (EPC) — a group of drugs that share a mechanism of action. pharmaranks lists 14 Anticholinergic products, each independently rated.
Are all Anticholinergic drugs the same?
No. Anticholinergic drugs share the same core mechanism — that is why they sit in one FDA class — but they differ in their approved uses, available forms, whether they are prescription or over-the-counter, brand-vs-generic options and price, and their FDA recall-safety record.
What conditions do Anticholinergic drugs treat?
Per NIH RxClass drug-classification data, Anticholinergic drugs are used for conditions including bronchial spasm, bronchitis, pulmonary emphysema, rhinitis, allergic, perennial, rhinitis, vasomotor, bronchitis, chronic.
Which Anticholinergic drug is best-rated?
By our independent rating, atrovent hfa currently ranks highest among Anticholinergic drugs. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
Sources: the Anticholinergic class definition and its member drugs come from the U.S. NLM RxClass (Established Pharmacologic Class); how the class works is summarized from Muscarinic Antagonists - StatPearls - NCBI Bookshelf. Ratings are pharmaranks’ independent FDA recall-safety analysis.